Skip to search formSkip to main contentSkip to account menu

loteprednol etabonate

Known as: 17-ethoxycarbonyloxy-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate, Chloromethyl, Etabonate, Loteprednol, Chloromethyl 17 ethoxycarbonyloxy 11 hydroxy 3 oxoandrosta 1,4 diene 17 carboxylate 
The etabonate salt form of loteprednol, an ophthalmic analog of the corticosteroid prednisolone with anti-inflammatory activity. Loteprednol… 
National Institutes of Health

Related topics

Related topics

24 relations
Allergic ConjunctivitisBacterial conjunctivitisDrug AllergyEdema

Narrower (2)

AlrexLotemax

Broader (2)

Anti-Allergic AgentsLoteprednol

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Topical loteprednol etabonate 0.5 % for treatment of vernal keratoconjunctivitis: efficacy and safety
PurposeTo evaluate the efficacy and safety of loteprednol etabonate (LE) 0.5 % in vernal keratoconjunctivitis (VKC) patients… 
Highly Cited
2011
Highly Cited
2011
Topical loteprednol pretreatment reduces cyclosporine stinging in chronic dry eye disease.
PURPOSE This retrospective, clinical comparative analysis describes differences in clinical signs and symptoms and medication… 
Review
2011
Review
2011
Intraocular pressure elevations with loteprednol etabonate: a retrospective chart review.
PURPOSE Ocular corticosteroids can cause elevations in intraocular pressure (IOP). The purpose of this study was to characterize… 
2009
2009
Long-term treatment with sergliflozin etabonate improves disturbed glucose metabolism in KK-A(y) mice.
2008
2008
Pharmacokinetics of the sequential metabolites of loteprednol etabonate in rats
Pharmacokinetics, metabolism and excretion of two sequential inactive metabolites of the soft corticosteroid loteprednol… 
Review
2004
Review
2004
Long-term Safety of Loteprednol Etabonate 0.2% in the Treatment of Seasonal and Perennial Allergic Conjunctivitis
Purpose. To determine the long-term safety of the topical steroid, loteprednol etabonate 0.2%, in the treatment of seasonal and… 
Review
2000
Review
2000
Loteprednol etabonate: a review of ophthalmic clinical studies.
Loteprednol etabonate (LE) is a corticosteroid designed using the "soft drug" concept of Bodor. LE has been extensively evaluated… 
2000
2000
Loteprednol etabonate: a soft steroid for the treatment of allergic diseases of the airways.
There are several approaches for developing new antiallergic/antiasthmatic agents. One of them is the improvement of an existing… 
2000
2000
Effect of cyclodextrins on the solubility and stability of a novel soft corticosteroid, loteprednol etabonate.
To increase the aqueous solubility and stability of the soft corticosteroid loteprednol etabonate (LE), drug complexation using… 
1997
1997
A double-masked, placebo-controlled evaluation of the efficacy and safety of loteprednol etabonate in the treatment of giant papillary conjunctivitis. The Loteprednol Etabonate Giant Papillary…
PURPOSE To evaluate the safety and effectiveness of loteprednol etabonate 0.5% ophthalmic suspension in reducing the ocular signs… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)